|
Facebook
Twitter
Linkedin
|
VSCP: 12th BIO CEO & Investor Conference
| Company News - VirtualScopics |
VirtualScopics , Inc., announces that Mr. Jeff Markin, the company's president and CEO, will be presenting a corporate overview at the upcoming 12th Annual BIO CEO & Investor Conference.
VirtualScopics , Inc. (VSCP), a leading provider of quantitative imaging for clinical trials, announced that Mr. Jeff Markin, the company's president and chief executive officer, will be presenting a corporate overview at the upcoming 12th Annual BIO CEO & Investor Conference at the Waldorf Astoria in New York City. Mr. Markin's presentation will be on Tuesday, February 9, 2010.
VirtualScopics , Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics ' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster.
Source: VirtualScopics
You can discuss about VirtualScopics and related topic in the VirtualScopics Company User Group.











